Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1228 ARTÍCULOS , VIENDO DEL 1156 AL 1170

Retromer in Polarized Protein Transport

Vergés M.

Int Rev Cell Mol Biol. 2016;323:129-79. doi: 10.1016/bs.ircmb.2015.12.005. Epub 2016 Feb 3.

Glycation in Parkinson's disease and Alzheimer's disease

Vicente Miranda H, El-Agnaf OM, Outeiro TF.

Mov Disord. 2016 Jun;31(6):782-90. doi: 10.1002/mds.26566. Epub 2016 Mar 4.

Clinical drug research in chronic central neurodegenerative disorders

Müller T, Foley P.

Expert Rev Neurother. 2016 May;16(5):497-504. doi: 10.1586/14737175.2016.1163220. Epub 2016 Mar 21.

A Systematic Review of the Prevalence of Oropharyngeal Dysphagia in Stroke, Parkinson's Disease, Alzheimer's Disease, Head Injury, and Pneumonia

Takizawa C, Gemmell E, Kenworthy J, Speyer R.

Dysphagia. 2016 Jun;31(3):434-41. doi: 10.1007/s00455-016-9695-9. Epub 2016 Mar 12.

Structure of amyloid oligomers and their mechanisms of toxicities: Targeting amyloid oligomers using novel therapeutic approaches

Salahuddin P, Fatima MT, Abdelhameed AS, Nusrat S, Khan RH.

Eur J Med Chem. 2016 May 23;114:41-58. doi: 10.1016/j.ejmech.2016.02.065. Epub 2016 Mar 2.

Chronic Stress and Glucocorticoids: From Neuronal Plasticity to Neurodegeneration

Vyas S, Rodrigues AJ, Silva JM, Tronche F, Almeida OF, Sousa N, Sotiropoulos I.

Neural Plast. 2016;2016:6391686. doi: 10.1155/2016/6391686. Epub 2016 Mar 10.

Mechanisms of protein homeostasis in health, aging and disease

Goloubinoff P.

Swiss Med Wkly. 2016 Apr 5;146:w14306. doi: 10.4414/smw.2016.14306. eCollection 2016.

Omega-3 fatty acids for the treatment of dementia

Burckhardt M, Herke M, Wustmann T, Watzke S, Langer G, Fink A.

Cochrane Database Syst Rev. 2016 Apr 11;4(4):CD009002. doi: 10.1002/14651858.CD009002.pub3.

Advances in nanomedicine for the treatment of Alzheimer's and Parkinson's diseases

Hernando S, Gartziandia O, Herran E, Pedraz JL, Igartua M, Hernandez RM.

Nanomedicine (Lond). 2016 May;11(10):1267-85. doi: 10.2217/nnm-2016-0019. Epub 2016 Apr 14.

Mild cognitive impairment in Parkinson's disease versus Alzheimer's disease

Besser LM, Litvan I, Monsell SE, Mock C, Weintraub S, Zhou XH, Kukull W.

Parkinsonism Relat Disord. 2016 Jun;27:54-60. doi: 10.1016/j.parkreldis.2016.04.007. Epub 2016 Apr 9.

The crucial impact of lysosomes in aging and longevity

Carmona-Gutierrez D, Hughes AL, Madeo F, Ruckenstuhl C.

Ageing Res Rev. 2016 Dec;32:2-12. doi: 10.1016/j.arr.2016.04.009. Epub 2016 Apr 26.

Cerebrospinal fluid biomarkers in Alzheimer's and Parkinson's diseases-From pathophysiology to clinical practice

Blennow K, Biscetti L, Eusebi P, Parnetti L.

Mov Disord. 2016 Jun;31(6):836-47. doi: 10.1002/mds.26656. Epub 2016 May 4.

Altered NR4A Subfamily Gene Expression Level in Peripheral Blood of Parkinson's and Alzheimer's Disease Patients

Montarolo F, Perga S, Martire S, Navone DN, Marchet A, Leotta D, Bertolotto A.

Neurotox Res. 2016 Oct;30(3):338-44. doi: 10.1007/s12640-016-9626-4. Epub 2016 May 9.

Methods for the Specific Detection and Quantitation of Amyloid-β Oligomers in Cerebrospinal Fluid

Schuster J, Funke SA.

J Alzheimers Dis. 2016 May 7;53(1):53-67. doi: 10.3233/JAD-151029.

Protein Amyloidogenesis Investigated by Small Angle Scattering

Ricci C, Spinozzi F, Mariani P, Ortore MG.

Curr Pharm Des. 2016;22(26):3937-49. doi: 10.2174/1381612822666160519113237.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias